Ziprasidone in the Psychosis Prodrome

NCT00635700 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Psychosis Prodrome

Interventions

DRUG: ziprasidone
DRUG: placebo

Sponsor

Yale University